NO20053677L - Process for the preparation of albumin - Google Patents
Process for the preparation of albuminInfo
- Publication number
- NO20053677L NO20053677L NO20053677A NO20053677A NO20053677L NO 20053677 L NO20053677 L NO 20053677L NO 20053677 A NO20053677 A NO 20053677A NO 20053677 A NO20053677 A NO 20053677A NO 20053677 L NO20053677 L NO 20053677L
- Authority
- NO
- Norway
- Prior art keywords
- stabilizer
- optionally
- albumin
- albumin solution
- groups
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 title abstract 6
- 108010088751 Albumins Proteins 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 5
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 125000001165 hydrophobic group Chemical group 0.000 abstract 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Det beskrives et terapeutisk anvendelig virusinaktivert albumin og en fremgangsmåte for fremstilling av terapeutisk anvendelig virusinaktiverte albuminer som kjennetegnes ved kombinasjonen av følgende trinn: (a) underkastelse av en første vandig albuminløsning en behandling for virusinaktivering etter SD-metoden gjennom kontakt med SD-reagenser ved en temperatur under 45°C, (b) fjerning av SD-reagensene ved oljeekstraksjon og påfølgende hydrofob interaksjonskromatografi, i det minste i det vesentlige, hvorunder det under kromatograferingen benyttes en hydrofob matriks, særlig en matriks som eventuelt hydrofobe grupper kan være bundet til, under den forutsetning at disse gruppene er alifatiske grupper med C>24, og hvor det oppnås en andre albuminløsning, som (c) eventuelt tilsettes én eller flere stabilisatorer innen gruppen sukker, aminosyrer og sukkeralkoholer, under forutsetning av at det som stabilisator ikke benyttes noen indol-stabilisator og ingen C6-C10-fettsyre, hvoretter (d) den andre, eventuelt stabilisator-tilsatte, albuminiøsning, sluttbehandles og sterilfiltreres og eventuelt påfylles den endelige beholder.A therapeutically useful virus-inactivated albumin is disclosed and a process for the preparation of therapeutically useful virus-inactivated albumins characterized by the combination of the following steps: (a) subjecting a first aqueous albumin solution to a virus inactivation treatment by SD method through contact with SD reagents by a (b) removing the SD reagents by oil extraction and subsequent hydrophobic interaction chromatography, at least substantially, during which a hydrophobic matrix, in particular a matrix to which hydrophobic groups may be attached, is used, during provided that these groups are aliphatic groups with C> 24 and where a second albumin solution is obtained, which (c) optionally one or more stabilizers are added within the group of sugars, amino acids and sugar alcohols, provided that no stabilizer is used as a stabilizer. stabilizer and no C6-C10 fatty acid, respectively (d) the other, optionally stabilizer added, albumin solution is final treated and sterile filtered and optionally refilled to the final container.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT2182003 | 2003-02-13 | ||
| PCT/EP2004/001397 WO2004071524A1 (en) | 2003-02-13 | 2004-02-13 | Albumin solution and method for the production thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053677D0 NO20053677D0 (en) | 2005-07-29 |
| NO20053677L true NO20053677L (en) | 2005-10-31 |
Family
ID=32854882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053677A NO20053677L (en) | 2003-02-13 | 2005-07-29 | Process for the preparation of albumin |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1592439B1 (en) |
| JP (1) | JP2006517938A (en) |
| KR (1) | KR20050103292A (en) |
| CN (1) | CN100384471C (en) |
| AT (1) | ATE362376T1 (en) |
| AU (1) | AU2004212324B2 (en) |
| BR (1) | BRPI0407458A (en) |
| CA (1) | CA2514163A1 (en) |
| CY (1) | CY1106793T1 (en) |
| DE (1) | DE502004003834D1 (en) |
| DK (1) | DK1592439T3 (en) |
| ES (1) | ES2285427T3 (en) |
| IL (1) | IL169828A0 (en) |
| MX (1) | MXPA05008276A (en) |
| NO (1) | NO20053677L (en) |
| PL (1) | PL376644A1 (en) |
| PT (1) | PT1592439E (en) |
| RS (1) | RS50891B (en) |
| RU (1) | RU2305556C2 (en) |
| UA (1) | UA80469C2 (en) |
| WO (1) | WO2004071524A1 (en) |
| ZA (1) | ZA200506452B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005023155A1 (en) * | 2005-05-13 | 2006-11-16 | Albutec Gmbh | albumin solution |
| EP1966239A1 (en) * | 2005-12-22 | 2008-09-10 | CSL Behring GmbH | Octanoate-reduced human albumin |
| ES2332846B1 (en) | 2007-10-26 | 2010-07-08 | Grifols, S.A. | USE OF THERAPEUTIC HUMAN ALBUMIN FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS AFFECTED BY COGNITIVE DISORDERS. |
| ES2294976B1 (en) | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "HIGH EFFECTIVE HUMAN ALBUMIN OBTAINING PROCEDURE FOR USE IN DETOXIFICATION THERAPY". |
| EP2382993A1 (en) | 2010-04-19 | 2011-11-02 | KTB Tumorforschungsgesellschaft mbH | Combination of drugs with protein-binding prodrugs |
| CN111195351A (en) * | 2020-01-20 | 2020-05-26 | 华兰生物工程重庆有限公司 | Preparation method of 5% low-concentration human serum albumin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0669961B2 (en) * | 1984-09-25 | 1994-09-07 | 株式会社ミドリ十字 | Immunoglobulin heat treatment method |
| US5094960A (en) * | 1988-10-07 | 1992-03-10 | New York Blood Center, Inc. | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography |
| US5250662A (en) * | 1989-10-05 | 1993-10-05 | Alpha Therapeutic Corporation | Albumin purification |
| DE19729778A1 (en) * | 1997-07-11 | 1999-01-21 | Blutspendedienst Der Drk Lande | Process for the preparation of virus-inactivated biological fluids |
| US5919907A (en) * | 1997-12-22 | 1999-07-06 | Shanbrom Technologies Llc | Preparation and utilization of a novel sterile albumin |
| IL136552A (en) * | 2000-06-05 | 2005-05-17 | Omrix Biopharmaceuticals Ltd | Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration |
-
2004
- 2004-02-13 DE DE502004003834T patent/DE502004003834D1/en not_active Expired - Lifetime
- 2004-02-13 CN CNB2004800038643A patent/CN100384471C/en not_active Expired - Fee Related
- 2004-02-13 AU AU2004212324A patent/AU2004212324B2/en not_active Ceased
- 2004-02-13 EP EP04710818A patent/EP1592439B1/en not_active Expired - Lifetime
- 2004-02-13 JP JP2006501841A patent/JP2006517938A/en active Pending
- 2004-02-13 UA UAA200508678A patent/UA80469C2/en unknown
- 2004-02-13 MX MXPA05008276A patent/MXPA05008276A/en active IP Right Grant
- 2004-02-13 RS YUP-2005/0624A patent/RS50891B/en unknown
- 2004-02-13 RU RU2005128507/15A patent/RU2305556C2/en not_active IP Right Cessation
- 2004-02-13 CA CA002514163A patent/CA2514163A1/en not_active Abandoned
- 2004-02-13 PT PT04710818T patent/PT1592439E/en unknown
- 2004-02-13 KR KR1020057014946A patent/KR20050103292A/en not_active Application Discontinuation
- 2004-02-13 WO PCT/EP2004/001397 patent/WO2004071524A1/en active IP Right Grant
- 2004-02-13 DK DK04710818T patent/DK1592439T3/en active
- 2004-02-13 PL PL376644A patent/PL376644A1/en unknown
- 2004-02-13 ES ES04710818T patent/ES2285427T3/en not_active Expired - Lifetime
- 2004-02-13 AT AT04710818T patent/ATE362376T1/en not_active IP Right Cessation
- 2004-02-13 BR BR0407458-0A patent/BRPI0407458A/en not_active IP Right Cessation
-
2005
- 2005-07-21 IL IL169828A patent/IL169828A0/en unknown
- 2005-07-29 NO NO20053677A patent/NO20053677L/en not_active Application Discontinuation
- 2005-08-12 ZA ZA200506452A patent/ZA200506452B/en unknown
-
2007
- 2007-08-07 CY CY20071101052T patent/CY1106793T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2285427T3 (en) | 2007-11-16 |
| CN100384471C (en) | 2008-04-30 |
| UA80469C2 (en) | 2007-09-25 |
| RS50891B (en) | 2010-08-31 |
| EP1592439B1 (en) | 2007-05-16 |
| DE502004003834D1 (en) | 2007-06-28 |
| DK1592439T3 (en) | 2007-09-10 |
| ATE362376T1 (en) | 2007-06-15 |
| CA2514163A1 (en) | 2004-08-26 |
| KR20050103292A (en) | 2005-10-28 |
| CN1798573A (en) | 2006-07-05 |
| AU2004212324B2 (en) | 2009-05-07 |
| RU2005128507A (en) | 2006-01-20 |
| EP1592439A1 (en) | 2005-11-09 |
| AU2004212324A1 (en) | 2004-08-26 |
| ZA200506452B (en) | 2007-01-31 |
| IL169828A0 (en) | 2011-08-01 |
| MXPA05008276A (en) | 2006-03-21 |
| JP2006517938A (en) | 2006-08-03 |
| WO2004071524A1 (en) | 2004-08-26 |
| RS20050624A (en) | 2007-06-04 |
| PT1592439E (en) | 2007-06-22 |
| CY1106793T1 (en) | 2012-05-23 |
| NO20053677D0 (en) | 2005-07-29 |
| BRPI0407458A (en) | 2006-01-31 |
| PL376644A1 (en) | 2006-01-09 |
| RU2305556C2 (en) | 2007-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0530173B1 (en) | Method for inactivating prions | |
| NO20053677L (en) | Process for the preparation of albumin | |
| CN105392795B (en) | The method for producing botulin toxin | |
| CN104042548B (en) | A kind of snail mucus extract and preparation method thereof and the application in cosmetics | |
| EP2464599B1 (en) | Fractionation of a waste liquor stream from nanocrystalline cellulose production | |
| CN102952187B (en) | Preparation method of high-purity bovine serum albumin | |
| CN105886583A (en) | Bovine bone marrow peptide extraction method | |
| CN105876442A (en) | Extraction method of sheep bone marrow peptides | |
| KR20160134657A (en) | Method for thermal permeabilization of a microalgae biomass | |
| JP2017521451A (en) | Method for extracting soluble proteins from microalgal biomass | |
| WO2021260041A3 (en) | Method for separation of potato proteins with reduced enzymatic activity from potato fruit juice | |
| CN105732820A (en) | Renaturation method of restructured human insulin prokaryotic-fusion protein | |
| BRPI0412835A (en) | process for preparing an alpha-1-antitrypsin solution | |
| IL86417A (en) | Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers | |
| DE3152621C2 (en) | ||
| BR0313045A (en) | Process for improving yield of recombinant plant protein production | |
| CN103695513A (en) | Method for improving yield of soybean peptide with low molecular weight | |
| CN106086132A (en) | A kind of utilize ginkgo nut leather for the method for anti-oxidation peptide | |
| Altuner | A predictive modelling study for using high hydrostatic pressure, a food processing technology, for protein extraction | |
| SE0100801L (en) | Method for pre-processing milk with microfiltration | |
| Islam et al. | Enzyme processing of soy flour with minimized protein loss | |
| US4894444A (en) | Recovery and purification of immunogens from immunogen-alum complexes | |
| CN106883307A (en) | A kind of method that grifola frondosus water extraction polysaccharide and alkali-extracted polysaccharide are isolated and purified | |
| Winicur | Reactivation of ethanol-calcium-isolated cilia from Tetrahymena pyriformis | |
| Gusarov et al. | Systematic Approach to Production Technology Development for Therapeutic Proteins (Using Insulin–Glargine as an Example) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |